Sex and gender disparities have been reported for different types of non-reproductive cancers. Males are two times more likely to develop kidney cancer than females and have a higher death rate. These differences can be explained by looking at genetics and genomics, as well as other risk factors such as hypertension and obesity, lifestyle, and female sex hormones. Examination of the hormonal signaling pathways bring further insights into sex-related differences. Sex and gender-based disparities can be observed at the diagnostic, histological and treatment levels, leading to significant outcome difference. This review summarizes the current knowledge about sex and gender-related differences in the clinical presentation of patients with kidney cancer and the possible biological mechanisms that could explain these observations. Underlying sex-based differences may contribute to the development of sex-specific prognostic and diagnostic tools and the improvement of personalized therapies.

Sex and gender differences in kidney cancer: Clinical and experimental evidence / Peired A.J.; Campi R.; Angelotti M.L.; Antonelli G.; Conte C.; Lazzeri E.; Becherucci F.; Calistri L.; Serni S.; Romagnani P.. - In: CANCERS. - ISSN 2072-6694. - ELETTRONICO. - 13:(2021), pp. 4588-4588. [10.3390/cancers13184588]

Sex and gender differences in kidney cancer: Clinical and experimental evidence

Peired A. J.
;
Campi R.;Angelotti M. L.;Antonelli G.;Conte C.;Lazzeri E.;Becherucci F.;Calistri L.;Serni S.;Romagnani P.
2021

Abstract

Sex and gender disparities have been reported for different types of non-reproductive cancers. Males are two times more likely to develop kidney cancer than females and have a higher death rate. These differences can be explained by looking at genetics and genomics, as well as other risk factors such as hypertension and obesity, lifestyle, and female sex hormones. Examination of the hormonal signaling pathways bring further insights into sex-related differences. Sex and gender-based disparities can be observed at the diagnostic, histological and treatment levels, leading to significant outcome difference. This review summarizes the current knowledge about sex and gender-related differences in the clinical presentation of patients with kidney cancer and the possible biological mechanisms that could explain these observations. Underlying sex-based differences may contribute to the development of sex-specific prognostic and diagnostic tools and the improvement of personalized therapies.
2021
13
4588
4588
Peired A.J.; Campi R.; Angelotti M.L.; Antonelli G.; Conte C.; Lazzeri E.; Becherucci F.; Calistri L.; Serni S.; Romagnani P.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1243825
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 28
  • ???jsp.display-item.citation.isi??? 22
social impact